179 related articles for article (PubMed ID: 31001468)
1. CACNA2D3 Enhances the Chemosensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin via Inducing Ca
Nie C; Qin X; Li X; Tian B; Zhao Y; Jin Y; Li Y; Wang Q; Zeng D; Hong A; Chen X
Front Oncol; 2019; 9():185. PubMed ID: 31001468
[TBL] [Abstract][Full Text] [Related]
2. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
[TBL] [Abstract][Full Text] [Related]
3. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
5. Investigation of tumor suppressing function of CACNA2D3 in esophageal squamous cell carcinoma.
Li Y; Zhu CL; Nie CJ; Li JC; Zeng TT; Zhou J; Chen J; Chen K; Fu L; Liu H; Qin Y; Guan XY
PLoS One; 2013; 8(4):e60027. PubMed ID: 23560067
[TBL] [Abstract][Full Text] [Related]
6. miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway.
Zheng TL; Li DP; He ZF; Zhao S
Cancer Cell Int; 2019; 19():250. PubMed ID: 31582906
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
[TBL] [Abstract][Full Text] [Related]
8. CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression.
Jin Z; Zhao L; Chang Y; Jin R; Hu F; Wu S; Xue Z; Ma Y; Chen C; Zheng M; Chang Y; Jin H; Xie Q; Huang C; Huang H
Cell Death Dis; 2023 Aug; 14(8):563. PubMed ID: 37633993
[TBL] [Abstract][Full Text] [Related]
9. CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.
Jin Y; Cui D; Ren J; Wang K; Zeng T; Gao L
Mol Carcinog; 2017 Mar; 56(3):945-959. PubMed ID: 27583705
[TBL] [Abstract][Full Text] [Related]
10. Progesterone induces cell apoptosis via the CACNA2D3/Ca2+/p38 MAPK pathway in endometrial cancer.
Kong X; Li M; Shao K; Yang Y; Wang Q; Cai M
Oncol Rep; 2020 Jan; 43(1):121-132. PubMed ID: 31746409
[TBL] [Abstract][Full Text] [Related]
11. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
Li DJ; Shi M; Wang Z
Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
[TBL] [Abstract][Full Text] [Related]
12. Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma
Wang J; Ji H; Zhu Q; Yu X; Du J; Jiang Z
Oncol Lett; 2019 Jun; 17(6):5012-5022. PubMed ID: 31186712
[TBL] [Abstract][Full Text] [Related]
13. CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation.
Liu Z; Gu S; Wu K; Li L; Dong C; Wang W; Zhou Y
J Exp Clin Cancer Res; 2021 Nov; 40(1):361. PubMed ID: 34781999
[TBL] [Abstract][Full Text] [Related]
14. Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways.
Chen J; Lan T; Zhang W; Dong L; Kang N; Fu M; Liu B; Liu K; Zhang C; Hou J; Zhan Q
Arch Biochem Biophys; 2015 Jun; 575():38-45. PubMed ID: 25843419
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells.
Wang J; Li L; Wu K; Ge W; Zhang Z; Gong L; Yuan D
Pharmazie; 2016 Oct; 71(10):598-602. PubMed ID: 29441929
[TBL] [Abstract][Full Text] [Related]
16. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
Yu X; Li W; Xia Z; Xie L; Ma X; Liang Q; Liu L; Wang J; Zhou X; Yang Y; Liu H
BMC Cancer; 2017 Jun; 17(1):449. PubMed ID: 28659182
[TBL] [Abstract][Full Text] [Related]
17. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
[TBL] [Abstract][Full Text] [Related]
18. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes.
Zeng RJ; Zheng CW; Gu JE; Zhang HX; Xie L; Xu LY; Li EM
Mol Oncol; 2019 Sep; 13(9):2010-2030. PubMed ID: 31314174
[TBL] [Abstract][Full Text] [Related]
19. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.
Wong AM; Kong KL; Chen L; Liu M; Wong AM; Zhu C; Tsang JW; Guan XY
Int J Cancer; 2013 Nov; 133(10):2284-95. PubMed ID: 23649311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
